Newsroom - Page 13

As the public grows increasingly outraged over the rising cost of prescription drugs, the cost of hospital inpatient drugs has been overlooked. According to a new report, inpatient drug spending increased 23.4% annually between 2013 and 2015.
A survey by Avalere Health found that only 19% of drug makers publicly post policies about their compassionate use programs.
The pay-for-performance deal comes as Januvia faces increased competition from newer drug classes, especially SGLT2 inhibitors and GLP-1 receptor agonists.
What we're reading, October 12, 2016: a US senator calls for a limit to prescription fentanyl; healthcare costs aren't skyrocketing, despite claims; IBM's Watson will identify cancer treatment and clinical trials for IBM employees.
A pilot analysis published online in JAMA Cardiology has concluded that Twitter offers promise as a data source for studying public communication about cardiovascular disease.
A study from Tufts University School of Medicine found that at age 10, obesity rates among children on the autism spectrum are not that much higher than children outside the spectrum, but rates diverge sharply as children get older.
A retrospective study in breast cancer patients suggests that patients can lower their out-of-pocket costs by speaking with their oncologist about alternate treatments that may be equally effective and understanding the drug coverage policy of their insurance plan.
Innovation in oncology treatments has reduced the mortality rate for cancer, but it comes at a price. At the 5th Annual Patient-Centered Oncology Care, experts will discuss cost-sharing models, as well as updates in cancer care treatment, such as precision medicine and immuno-oncology.
Diabetes Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium